Funded Tech Companies
Cellectar Biosciences
Cellectar Biosciences is a leading biopharmaceutical venture, based in Florham Park. Financial backing was provided by Balyasny Asset Management, SilverArc Capital and Stonepine Capital Management.
Company Overview
Company Name
Cellectar Biosciences
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
100 Campus Dr. 207
Florham Park, NJ 07932
USA
Florham Park, NJ 07932
USA
Phone
Website
Email Address
Company Background Information
Overview
Cellectar Biosciences develops targeted cancer therapies using our proprietary PLE platform to precisely treat tumors while minimizing harm to healthy tissue. We focus on improving outcomes for patients with advanced cancers where better options are urgently needed. We envision a future where patients with even the most advanced cancers have access to effective, well-tolerated therapies that improve survival and quality of life.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/5/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Douglas Swirsky
Chief Executive Officer
James Caruso
Chief Financial Officer
Chad Kolean
VP - Bus. Development
Jarrod Longcor
Company Investors
- Balyasny Asset Management
- SilverArc Capital
- Stonepine Capital Management
- Nantahala Capital Management (Andrew Gu)
- Janus Henderson Investors
- Advantage Capital Partners
- Venture Investors (John Neis)
Browse more funded tech companies:
Cellcolabs | Cellerant Therapeutics
Share this article
About Our Venture Capital Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs